Skip to main navigation Skip to search Skip to main content

Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose

  • Juan Luis Rodriguez-Tudela
  • , Alicia Gomez-Lopez
  • , Maiken C. Arendrup
  • , Guillermo Garcia-Effron
  • , David S. Perlin
  • , Cornelia Lass-Flörl
  • , Manuel Cuenca-Estrella
  • Instituto de Salud Carlos III
  • Statens Serum Institut
  • Universidad Nacional del Litoral
  • Public Health Research Institute, New York
  • Innsbruck Medical University

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

According to the product insert for Cancidas (caspofungin acetate), the drug must not be diluted in solutions containing glucose as this decreases caspofungin stability. The aim of this study was to compare caspofungin MICs for a collection of yeasts by means of EUCAST method EDef7.1 but using two different concentrations of glucose: 2% versus 0.2%. MICs were identical or within one 2-fold dilution for 93 out of 95 strains (97.9%), showing that glucose does not interfere with susceptibility.

Original languageEnglish
Pages (from-to)3056-3057
Number of pages2
JournalAntimicrobial Agents and Chemotherapy
Volume54
Issue number7
DOIs
StatePublished - Jul 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose'. Together they form a unique fingerprint.

Cite this